SARAH FRAZIER: Open Payments
NPI 1942448303 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,932 in 129 payments from 18 companies in 2025. Trend: 2023 $2,064 · 2024 $2,171 · 2025 $2,932
Food & beverage: $2,932
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $672 |
| Incyte Corporation | 15 | $349 |
| UCB, Inc. | 10 | $346 |
| ABBVIE INC. | 20 | $330 |
| Novartis Pharmaceuticals Corporation | 19 | $329 |
| GENZYME CORPORATION | 7 | $255 |
| Janssen Biotech, Inc. | 11 | $144 |
| Lilly USA, LLC | 8 | $136 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $112 |
| LEO Pharma Inc. | 2 | $52 |
Products named: NEMLUVIO, OPZELURA, Bimzelx, COSENTYX, DUPIXENT, RINVOQ, SKYRIZI, TREMFYA.
Industry payments across CA — which companies pay providers there.
